Drug-Device Combination Products

Drug-Device Combination Products
Author :
Publisher : Elsevier
Total Pages : 561
Release :
ISBN-10 : 9781845697488
ISBN-13 : 1845697480
Rating : 4/5 (480 Downloads)

Book Synopsis Drug-Device Combination Products by : Andrew Lewis

Download or read book Drug-Device Combination Products written by Andrew Lewis and published by Elsevier. This book was released on 2009-12-15 with total page 561 pages. Available in PDF, EPUB and Kindle. Book excerpt: Drug delivery systems represent a vast area of research and development within biomaterials and medicine and the demand for sophisticated drug delivery devices continues to drive novel product development. Advanced drug delivery devices can offer significant advantages over conventional drugs and devices alone, such as increased efficiency, improved performance and convenience. The purpose of this book is to illustrate how effective drug delivery can be achieved by means other than tablets. The book will provide a thorough analysis of the fundamentals, applications and new technologies of drug-device combination products for use throughout the human body.Part one provides readers with an introduction and background to the field. Chapters in Part two discuss areas of application such as catheter based products, drug eluting stents and beads and anti-biotic loaded cements. Part three covers the development of drug device combination products with chapters on such topics as pre-clinical testing, sterilisation, patent issues and regulation of drug device combination products.With its distinguished editor and team of international contributors, Drug-device combination products: delivery technologies and applications is an invaluable reference for product development specialists, materials scientists and engineers in the biomedical industry and academia as well as those concerned with drug delivery. - Illustrates how effective drug delivery can be achieved by means other than tablets providing readers with a comprehensive introduction and background to the field - Provides a thorough analysis of the fundamentals, applications and new technologies of drug device combination products - Discusses areas of application such as catheter based products and reviews the development of drug device combination products including pre-clinical testing and sterilisation


Drug-Device Combination Products Related Books

Drug-Device Combination Products
Language: en
Pages: 561
Authors: Andrew Lewis
Categories: Technology & Engineering
Type: BOOK - Published: 2009-12-15 - Publisher: Elsevier

DOWNLOAD EBOOK

Drug delivery systems represent a vast area of research and development within biomaterials and medicine and the demand for sophisticated drug delivery devices
Integrated Safety and Risk Assessment for Medical Devices and Combination Products
Language: en
Pages: 496
Authors: Shayne C. Gad
Categories: Medical
Type: BOOK - Published: 2020-02-24 - Publisher: Springer Nature

DOWNLOAD EBOOK

While the safety assessment (“biocompatibility”) of medical devices has been focused on issues of local tissue tolerance (irritation, sensitization, cytotox
Development of Biopharmaceutical Drug-Device Products
Language: en
Pages: 888
Authors: Feroz Jameel
Categories: Medical
Type: BOOK - Published: 2020-03-13 - Publisher: Springer Nature

DOWNLOAD EBOOK

The biotechnology/biopharmaceutical sector has tremendously grown which led to the invention of engineered antibodies such as Antibody Drug Conjugates (ADCs), B
Biomaterials, Medical Devices, and Combination Products
Language: en
Pages: 698
Authors: Shayne Cox Gad
Categories: Medical
Type: BOOK - Published: 2015-12-01 - Publisher: CRC Press

DOWNLOAD EBOOK

Biomaterials, Medical Devices, and Combination Products is a single-volume guide for those responsible for-or concerned with-developing and ensuring patient saf
Medical Devices and the Public's Health
Language: en
Pages: 318
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2011-11-25 - Publisher: National Academies Press

DOWNLOAD EBOOK

Medical devices that are deemed to have a moderate risk to patients generally cannot go on the market until they are cleared through the FDA 510(k) process. In